Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy
Objective: Glucosamine, an intermetabolite of the hexosamine biosynthesis pathway (HBP), is a widely used nutritional supplement in osteoarthritis patients, a subset of whom also suffer from diabetes. HBP is activated in diabetic retinopathy (DR). The aim of this study is to investigate the yet uncl...
Saved in:
Main Authors: | Rachana Eshwaran (Author), Matthias Kolibabka (Author), Gernot Poschet (Author), Gregor Jainta (Author), Di Zhao (Author), Loic Teuma (Author), Katharina Murillo (Author), Hans-Peter Hammes (Author), Martina Schmidt (Author), Thomas Wieland (Author), Yuxi Feng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contribution of the hexosamine biosynthetic pathway in the hyperglycemia-dependent and -independent breakdown of the retinal neurovascular unit
by: Yixin Wang, et al.
Published: (2023) -
Photoallergic Dermatitis To Glucosamine
by: Goel Ashima, et al.
Published: (2003) -
The Glucosamine Controversy; A Pharmacokinetic Issue
by: Ali Aghazadeh-Habashi, et al.
Published: (2011) -
Sufficient Cav-1 levels in the endothelium are critical for the maintenance of the neurovascular unit in the retina
by: Yixin Wang, et al.
Published: (2023) -
Glucosamine as a Treatment for Osteoarthritis: What If It's True?
by: Thierry Conrozier, et al.
Published: (2022)